Was wondering why their FY21 costs where much higher than first half of this year, this probably explains it:

> Stock-based compensation expense for fiscal 2020 and 2021, and six months ended July 31, 2021 includes $32.7 million, $103.8 million, and $0.3 million, respectively, of compensation expense related to secondary stock sales described in Note 16 to our consolidated financial statements included elsewhere in this prospectus.

Which makes the numbers not as bad as they seem on first glance.